Life Technologies Recalls HSV-2 Primers Due to Amplification Failure
Life Technologies is recalling 15 kits of HSV-2 Primers because they failed to amplify HSV-2 DNA. The products were distributed in Delaware, Iowa, Minnesota, and North Carolina.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II. The hazard involves a functional failure of a diagnostic reagent (failure to amplify DNA) without reported injuries or illnesses, fitting the criteria for a moderate severity recall involving low-risk contamination or functional defects.
Plain-English summary
Life Technologies Corporation is recalling 15 kits of HSV 2 Primers, Catalog #18081020. These products are Analyte Specific Reagents intended for use in clinical laboratories when developing their own diagnostic tests for Herpes Simplex Virus 2 (HSV-2).
The recall was initiated after the firm received complaints that the HSV-2 primers failed to amplify HSV-2 DNA. The affected products are identified by Lot #1368760 and Lot #1312093.
The recalled products were distributed nationwide in the United States, specifically in the states of Delaware, Iowa, Minnesota, and North Carolina. Clinical laboratories should stop using these specific lots and contact Life Technologies Corporation for further instructions.
The recalled product
- Product
- HSV 2 Primers, Catalog #18081020. Analyte Specific Reagent. The HSV-2 primer pair is specific for HSV-2 (Herpes Simplex Virus 2). For use in Clinical laboratories when developing their own diagnostic tests.
- Manufacturer
- Life Technologies Corporation
- Hazard
- Affected units
- 15
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Catalog #18081020
- Lot #1368760 & Lot #1312093
Distribution
Related recalls
Same manufacturer · Life Technologies Corporation
See all →- HighTorrent Suite Dx Software versions affected by cybersecurity vulnerability
FDA (Devices) · 2024-04-10
- HighLife Technologies Recalls TaqPath RT-PCR COVID-19 Kit Software
FDA (Devices) · 2020-09-23
- HighLife Technologies Recalls TaqPath RT-PCR COVID-19 Kit Software
FDA (Devices) · 2020-09-23
- ModerateLife Technologies Recalls Oncomine Dx Target Test DNA Control-IVD
FDA (Devices) · 2020-04-22
- ModerateLife Technologies Recalls Oncomine Dx Target Test RNA Control for Expiration Date Error
FDA (Devices) · 2020-04-22
Same hazard · diagnostic failure
See all →- HighGC Agar Base Culture Media Reduced Recovery of Neisseria gonorrhoeae
FDA (Devices) · 2026-07-08
- HighLuminex VERIGENE Gram Negative Blood Culture Test Recalled
FDA (Devices) · 2025-06-11
- HighChevrolet Bolt battery diagnostic software may miss defective modules
NHTSA · 2024-06-27
- HighBD SARS-CoV-2 Reagent Kits Recalled for False Negative Test Results
FDA (Devices) · 2024-06-12
- ModerateBD Phoenix Yeast ID Panel Recalled for Incorrect Substrate Placement
FDA (Devices) · 2024-04-10